Instinct Bio Technical Company Holdings Inc

Análisis de la acción Instinct Bio Technical Company Holdings Inc (BIOT)

$0.183

-0.020 (-10.75%)Al cierre

Loading chart…
Máximo
0.210
Apertura
0.200
Precio medio ponderado por volumen
0.19
Volumen
1.21M
Capitalización
—
Mínimo
0.166
Importe
225.44K
EV/EBITDA, TTM
0.00

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others.

instinct-biot.com

Análisis de IA of Instinct Bio Technical Company Holdings Inc (BIOT)

Vender

Currently, Relativity Holdings Inc. (BIOT) is not a good buy. The stock has seen a staggering year-to-date change of -99.50%, indicating severe underperformance. Additionally, the RSI is at a very low 6.955, suggesting that the stock is extremely oversold. The stock's price is currently at 0.18, which is significantly below its 200-day simple moving average of 1.211, indicating a strong downtrend. The main risk is the lack of any positive financial metrics, as the forward P/E ratio is 0, which means there are no earnings expected in the near future. Overall, the combination of extreme price decline and poor fundamentals suggests that investors should avoid buying BIOT at this time.

Métricas de valoración

El PER previsto actual de Instinct Bio Technical Company Holdings Inc (BIOT) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E
P/E actual
0.00

EV/EBITDA previsto

Media 5A EV/EBITDA
EV/EBITDA actual
0.00

Precio/ventas previsto

Media 5A P/S
P/S actual
0.00

Preguntas frecuentes sobre BIOT, respondidas por Alphio AI

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others. It operates in the Consumer Non-Cyclicals sector.

Currently, Relativity Holdings Inc. (BIOT) is not a good buy. The stock has seen a staggering year-to-date change of -99.50%, indicating severe underperformance. Additionally, the RSI is at a very low 6.955, suggesting that the stock is extremely oversold. The stock's price is currently at 0.18, which is significantly below its 200-day simple moving average of 1.211, indicating a strong downtrend. The main risk is the lack of any positive financial metrics, as the forward P/E ratio is 0, which means there are no earnings expected in the near future. Overall, the combination of extreme price decline and poor fundamentals suggests that investors should avoid buying BIOT at this time.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar